SangHoon Choi Email

Scientist . Samsung Bioepis

Current Roles

Employees:
789
Revenue:
$253.7M
About
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. Samsung Bioepis is a joint venture between Samsung BioLogics and Biogen. For more information, please visit: www.samsungbioepis.com.
Samsung Bioepis Address

null, null
Samsung Bioepis Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.